Prof. Dr. Renata Stripecke


Chair of Translational Immune Oncology



Principal Investigator’s Curriculum Vitae

1983-88
Bachellor’s Degree in Biological Sciences and Master’s Degree in Genetics at the State University of Campinas, Sao Paulo, Brazil.
1993
“Doktor der Naturwissenschaften” at the University Heidelberg and European Molecular Biology Laboratory (EMBL), Germany.
2002
“Habilitation” in Genetics and Molecular Biology, Eppendorf University Clinic, Hamburg, Germany.
1994-96
Post-doctoral fellow Howard Hughes medical Insitute – UCLA, USA.
1996-99
Research Associate at Childrens Hospital Los Angeles, USC, CA, USA, with Prof. Dr. med. Donald Kohn.
1999-03 
Assistant Professor of Research, Dept. Pathology, School of Medicine, University of Southern California (USC), Los Angeles, CA, USA.
2003-07 
Assistant Professor, Dept. Medicine and Co-director Molecular Vector Core, University of California, Los Angeles (UCLA), CA, USA.
2008-22
W2 Professorship Clinic of Hematology, Oncology, Homeostasis and Stem Cell Transplantation and funded by the DFG Excellence Cluster Rebirth, Hannover Medical School  (MHH), Germany.
2012-16 
Vice-chair of the Regenerative Sciences PhD program, REBIRTH, MHH.
2015 
W2 Tenure („Beamtin auf Lebenszeit“) “Regenerative Immune Therapies Applied”, MHH.
2015
Visiting Professor, Advanced Cell and Gene Therapy, Baylor College of Medicine, Houston, USA (Profs. Cliona Rooney and Malcolm Brenner).
2015-22
Member of the German Center for Infection Research Hannover-Brunswick 
2022
W3 Professorship Translational Immuno-Oncology, Clinic of Internal Medicine 1 of the University Hospital Cologne, University of Cologne, and funded by the Government of North-Rhine Westphalia 
2023
Member of the Center for Molecular Medicine Cologne (CMMC) 
2023 
Deputy Committee Member of the Interdisciplinary Program in Molecular Medicine (IPMM) doctorate programme
2023
Member of the German Center for Infection Research Bonn-Cologne

Activities in Private Sector
2019- 
Scientific Academic Partnership, The Jackson Laboratory, Sacramento, USA.
2020- 
Scientific Advisor and Shareholder Biosyngen/ Zelltechs Pte. Ltd., Republic of Singapore.
2020-21 
Scientific Advisor, Orgenesis Inc., USA.

Prizes & Nominations
1988-90
Konrad-Adenauer-Stiftung, Scholarship (Germany).
1994-95
DFG, Post-doctoral Scholarship (Germany).
1999-00 
Leukemia and Lymphoma Society, Special Fellow Award (USA).
2000-03  
National Cancer Institute/NIH, K01/ Howard Temin Award (USA).
2001-02 
DFG, Habilitation Scholarship (Germany).
2015
DFG, grant for sabbatical and international collaboration (BCM, USA)
2016-17
American Society of Gene and Cell Therapy (ASGCT), International Committee Member (2016-17), International Committee Chair (2017-18), Educational Committee (2019-24), Cancer Immunotherapy (2023-25)
 
Reviewer for Funding Agencies (selected):
 German Research Council (DFG), German Cancer Aid (DKH), Else-Kröner Fresenius Foundation (EKFS), German Jose Carreras Leukemia Foundation (DJCLS), Concern Foundation

 Active Member of Societies:
 American Society of Gene and Cell Therapy (www.asgct.org),  Association for Cancer Immunotherapy (www.cimt.eu)

Member of the Editorial Board of Scientific Journals
Frontiers in Immunology, Molecular Therapy Methods, Cancer Gene Therapy, Biomedicines

Publications 

Network
https://de.linkedin.com/in/renata-stripecke-b5a78020


Patents as Main Inventor